関連する実験動画
Updated: May 5, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
21.6K
MA026の全合成と抗肝炎Cウイルス活性
Satomi Shimura1, Masahiro Ishima, Syo Nakajima
1Department of Applied Biological Science, Tokyo University of Sciences , Noda, Chiba 278-8510, Japan.
Journal of the American Chemical Society
|November 21, 2013
まとめ
研究者は新しい化合物であるMA026を合成し,クラウジン-1を標的にすることで,C型肝炎ウイルス (HCV) の侵入を抑制することを発見しました. この合成により,HCV治療に関するさらなる研究が可能になる.
科学分野:
- 有機化学 オーガニック・ケミストリー
- ウイルス学 ウイルス学 ウイルス学
- 分子生物学は分子生物学である.
背景:
- C型肝炎ウイルス (HCV) 感染症は,世界的な健康上の課題であり続けています.
- 新種の抗ウイルス薬は,HCVと戦うために必要である.
- MA026は,潜在的な抗HCV活性を持つリポサイクロデプシペプチドです.
研究 の 目的:
- MA026.2 の最初の完全合成を達成するために.
- 抗HCV活動のためのMA026の分子標的を特定するために.
主な方法:
- 収束溶液相合成戦略.
- 感染性HCV細胞培養試験. 感染性HCV細胞培養試験.
- ファージディスプレイスクリーニングと表面プラズモン共鳴 (SPR) 分析.
主要な成果:
- MA026.2の完全な合成が成功しました.
- MA026は,HCVの肝細胞への侵入を,投与量に依存した方法で抑制する.
- クラウジン-1は,MA026の抗HCV活性のための候補標的タンパク質として特定されました.
結論:
- 開発された合成は,MA026アナログを生成するために多用途です.
- MA026は,ウイルスの侵入をターゲットにすることで,HCVに対する有望な治療候補である.
- クラウジン-1は,MA026の抗ウイルスメカニズムの重要な媒介体です.
さらに関連する動画
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
12.9K
関連する概念動画
01:30Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
01:07MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
01:25Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
01:25cAMP-dependent Protein Kinase Pathways
7.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
01:28Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K